Autoimmune Disease Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1066268
  • May 2021
  • Pharmaceuticals
  • 142 Pages
The global Autoimmune Disease Therapeutics market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Autoimmune Disease Therapeutics market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Autoimmune Disease Therapeutics market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Autoimmune Disease Therapeutics market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Amgen Inc., F. Hoffmann-La Roche Ag, Bayer Schering Pharma Ag, Biogen Idec Inc., Bristol-Myers Squibb Company, Eli Lilly And Company, Abbott Laboratories, Genentech Inc., Merck & Co. Inc., Johnson & Johnson Inc.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Autoimmune Disease Therapeutics market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Autoimmune Disease Therapeutics market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Autoimmune Disease Therapeutics market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Autoimmune Disease Therapeutics market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Autoimmune Disease Therapeutics Market:
The Autoimmune Disease Therapeutics market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Amgen Inc., F. Hoffmann-La Roche Ag, Bayer Schering Pharma Ag, Biogen Idec Inc., Bristol-Myers Squibb Company, Eli Lilly And Company, Abbott Laboratories, Genentech Inc., Merck & Co. Inc., Johnson & Johnson Inc.

Autoimmune Disease Therapeutics Market Segment Analysis:
by Drug Class
Immunosuppressant\'s
Anti-Inflammatory Drugs
Corticosteroids
Nonsteroidal anti-inflammatory drugs
Biologics
Distribution Channel
Hospitals
Clinics
Drug Stores
Independent pharmacies

Geographic Coverage for Autoimmune Disease Therapeutics Market:
The market research report on global Autoimmune Disease Therapeutics market offers complete analysis across various regions across the world. The Autoimmune Disease Therapeutics market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Autoimmune Disease Therapeutics market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Autoimmune Disease Therapeutics Market Value and Forecast
  • US
  • Canada
Europe Autoimmune Disease Therapeutics Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Autoimmune Disease Therapeutics Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Autoimmune Disease Therapeutics Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Autoimmune Disease Therapeutics Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Autoimmune Disease Therapeutics market report:
  • The report provides key trends of the global Autoimmune Disease Therapeutics market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Autoimmune Disease Therapeutics industry
  • The report covers all the recent developments of the Autoimmune Disease Therapeutics market and helps to provide current industry updates
  • The report covers a detailed look over the global Autoimmune Disease Therapeutics Industry and provides with significant actionable insights
  • The Autoimmune Disease Therapeutics market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Autoimmune Disease Therapeutics market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Autoimmune Disease Therapeutics market
  • Comprehensive analysis of the Autoimmune Disease Therapeutics market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Autoimmune Disease Therapeutics market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Autoimmune Disease Therapeutics market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Autoimmune Disease Therapeutics market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Autoimmune Disease Therapeutics market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Autoimmune Disease Therapeutics market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Amgen Inc.
  • F. Hoffmann-La Roche Ag
  • Bayer Schering Pharma Ag
  • Biogen Idec Inc.
  • Bristol-Myers Squibb Company
  • Eli Lilly And Company
  • Abbott Laboratories
  • Genentech Inc.
  • Merck & Co. Inc.
  • Johnson & Johnson Inc.
  • Immunosuppressant's
  • Anti-Inflammatory Drugs
  • Corticosteroids
  • Nonsteroidal anti-inflammatory drugs
  • Biologics
  • Hospitals
  • Clinics
  • Drug Stores
  • Independent pharmacies

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Autoimmune Disease Therapeutics Market Snapshot
          2.1.1. Global Autoimmune Disease Therapeutics Market By s Drug Class,2019
               2.1.1.1.Immunosuppressant's
               2.1.1.2.Anti-Inflammatory Drugs
               2.1.1.3.Corticosteroids
               2.1.1.4.Nonsteroidal anti-inflammatory drugs
               2.1.1.5.Biologics
          2.1.2. Global Autoimmune Disease Therapeutics Market By Distribution Channel,2019
               2.1.2.1.Hospitals
               2.1.2.2.Clinics
               2.1.2.3.Drug Stores
               2.1.2.4.Independent pharmacies
          2.1.3. Global Autoimmune Disease Therapeutics Market By End-use,2019
          2.1.4. Global Autoimmune Disease Therapeutics Market By Geography,2019

3. Global Autoimmune Disease Therapeutics Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Autoimmune Disease Therapeutics Market Size (US$), By s Drug Class, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By s Drug Class, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By s Drug Class, 2020
     4.2. Global Autoimmune Disease Therapeutics Market Size (US$), By s Drug Class, 2018 – 2028

5. Global Autoimmune Disease Therapeutics Market Size (US$), By Distribution Channel, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Distribution Channel, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Distribution Channel, 2020
     5.2. Global Autoimmune Disease Therapeutics Market Size (US$), By Distribution Channel, 2018 – 2028

6. Global Autoimmune Disease Therapeutics Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Autoimmune Disease Therapeutics Market Size (US$), By End-use, 2018 – 2028

7. Global Autoimmune Disease Therapeutics Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Autoimmune Disease Therapeutics Market Analysis, 2018 – 2028 
          7.2.1. North America Autoimmune Disease Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Autoimmune Disease Therapeutics Market Size (US$), By s Drug Class, 2018 – 2028
          7.2.3. North America Autoimmune Disease Therapeutics Market Size (US$), By Distribution Channel, 2018 – 2028
          7.2.4. North America Autoimmune Disease Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Autoimmune Disease Therapeutics Market Analysis, 2018 – 2028 
          7.3.1.  Europe Autoimmune Disease Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Autoimmune Disease Therapeutics Market Size (US$), By s Drug Class, 2018 – 2028
          7.3.3. Europe Autoimmune Disease Therapeutics Market Size (US$), By Distribution Channel, 2018 – 2028
          7.3.4. Europe Autoimmune Disease Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Autoimmune Disease Therapeutics Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Autoimmune Disease Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Autoimmune Disease Therapeutics Market Size (US$), By s Drug Class, 2018 – 2028
          7.4.3. Asia Pacific Autoimmune Disease Therapeutics Market Size (US$), By Distribution Channel, 2018 – 2028
          7.4.4. Asia Pacific Autoimmune Disease Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Autoimmune Disease Therapeutics Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Autoimmune Disease Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Autoimmune Disease Therapeutics Market Size (US$), By s Drug Class, 2018 – 2028
          7.5.3. Latin America Autoimmune Disease Therapeutics Market Size (US$), By Distribution Channel, 2018 – 2028
          7.5.4. Latin America Autoimmune Disease Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Autoimmune Disease Therapeutics Market Analysis, 2018 – 2028 
          7.6.1.  MEA Autoimmune Disease Therapeutics Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Autoimmune Disease Therapeutics Market Size (US$), By s Drug Class, 2018 – 2028
          7.6.3. MEA Autoimmune Disease Therapeutics Market Size (US$), By Distribution Channel, 2018 – 2028
          7.6.4. MEA Autoimmune Disease Therapeutics Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Autoimmune Disease Therapeutics Providers
        8.4.1 Amgen Inc.
                8.4.1.1 Business Description
                8.4.1.2 Amgen Inc. Geographic Operations
                8.4.1.3 Amgen Inc. Financial Information
                8.4.1.4 Amgen Inc. Product Positions/Portfolio
                8.4.1.5 Amgen Inc. Key Developments
        8.4.2 F. Hoffmann-La Roche Ag
                8.4.2.1 Business Description
                8.4.2.2 F. Hoffmann-La Roche Ag Geographic Operations
                8.4.2.3 F. Hoffmann-La Roche Ag Financial Information
                8.4.2.4 F. Hoffmann-La Roche Ag Product Positions/Portfolio
                8.4.2.5 F. Hoffmann-La Roche Ag Key Developments
        8.4.3 Bayer Schering Pharma Ag
                8.4.3.1 Business Description
                8.4.3.2 Bayer Schering Pharma Ag Geographic Operations
                8.4.3.3 Bayer Schering Pharma Ag Financial Information
                8.4.3.4 Bayer Schering Pharma Ag Product Positions/Portfolio
                8.4.3.5 Bayer Schering Pharma Ag Key Developments
        8.4.4 Biogen Idec Inc.
                8.4.4.1 Business Description
                8.4.4.2 Biogen Idec Inc. Geographic Operations
                8.4.4.3 Biogen Idec Inc. Financial Information
                8.4.4.4 Biogen Idec Inc. Product Positions/Portfolio
                8.4.4.5 Biogen Idec Inc. Key Developments
        8.4.5 Bristol-Myers Squibb Company
                8.4.5.1 Business Description
                8.4.5.2 Bristol-Myers Squibb Company Geographic Operations
                8.4.5.3 Bristol-Myers Squibb Company Financial Information
                8.4.5.4 Bristol-Myers Squibb Company Product Positions/Portfolio
                8.4.5.5 Bristol-Myers Squibb Company Key Developments
        8.4.6 Eli Lilly And Company
                8.4.6.1 Business Description
                8.4.6.2 Eli Lilly And Company Geographic Operations
                8.4.6.3 Eli Lilly And Company Financial Information
                8.4.6.4 Eli Lilly And Company Product Positions/Portfolio
                8.4.6.5 Eli Lilly And Company Key Developments
        8.4.7 Abbott Laboratories
                8.4.7.1 Business Description
                8.4.7.2 Abbott Laboratories Geographic Operations
                8.4.7.3 Abbott Laboratories Financial Information
                8.4.7.4 Abbott Laboratories Product Positions/Portfolio
                8.4.7.5 Abbott Laboratories Key Developments
        8.4.8 Genentech Inc.
                8.4.8.1 Business Description
                8.4.8.2 Genentech Inc. Geographic Operations
                8.4.8.3 Genentech Inc. Financial Information
                8.4.8.4 Genentech Inc. Product Positions/Portfolio
                8.4.8.5 Genentech Inc. Key Developments
        8.4.9 Merck & Co. Inc.
                8.4.9.1 Business Description
                8.4.9.2 Merck & Co. Inc. Geographic Operations
                8.4.9.3 Merck & Co. Inc. Financial Information
                8.4.9.4 Merck & Co. Inc. Product Positions/Portfolio
                8.4.9.5 Merck & Co. Inc. Key Developments
        8.4.10 Johnson & Johnson Inc.
                8.4.10.1 Business Description
                8.4.10.2 Johnson & Johnson Inc. Geographic Operations
                8.4.10.3 Johnson & Johnson Inc. Financial Information
                8.4.10.4 Johnson & Johnson Inc. Product Positions/Portfolio
                8.4.10.5 Johnson & Johnson Inc. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Autoimmune Disease Therapeutics Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Autoimmune Disease Therapeutics Market Revenue, By s Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Autoimmune Disease Therapeutics Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Autoimmune Disease Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Autoimmune Disease Therapeutics Market Revenue, By s Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Autoimmune Disease Therapeutics Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Autoimmune Disease Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Autoimmune Disease Therapeutics Market Revenue, By s Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Autoimmune Disease Therapeutics Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Autoimmune Disease Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Autoimmune Disease Therapeutics Market Revenue, By s Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Autoimmune Disease Therapeutics Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Autoimmune Disease Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Autoimmune Disease Therapeutics Market Revenue, By s Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Autoimmune Disease Therapeutics Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Autoimmune Disease Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Autoimmune Disease Therapeutics: Market Segmentation 
FIG. 2 Global Autoimmune Disease Therapeutics Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Autoimmune Disease Therapeutics Market, By s Drug Class, 2019 (US$ Mn) 
FIG. 5 Global Autoimmune Disease Therapeutics Market, By Distribution Channel, 2019 (US$ Mn) 
FIG. 6 Global Autoimmune Disease Therapeutics Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Autoimmune Disease Therapeutics Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Autoimmune Disease Therapeutics Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Autoimmune Disease Therapeutics Providers, 2019
FIG. 11 Global Autoimmune Disease Therapeutics Market Revenue Contribution, By s Drug Class, 2019 & 2028 (Value %) 
FIG. 12 Global Autoimmune Disease Therapeutics Market Revenue Contribution, By Distribution Channel, 2019 & 2028 (Value %) 
FIG. 13 Global Autoimmune Disease Therapeutics Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Autoimmune Disease Therapeutics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Autoimmune Disease Therapeutics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Autoimmune Disease Therapeutics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Autoimmune Disease Therapeutics Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Autoimmune Disease Therapeutics Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Autoimmune Disease Therapeutics market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Autoimmune Disease Therapeutics Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Autoimmune Disease Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  North America Autoimmune Disease Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  North America Autoimmune Disease Therapeutics Market Value, By Country, 2018 – 2028
TABLE  Europe Autoimmune Disease Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  Europe Autoimmune Disease Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  Europe Autoimmune Disease Therapeutics Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Autoimmune Disease Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Autoimmune Disease Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Autoimmune Disease Therapeutics Market Value, By Country, 2018 – 2028
TABLE  Latin America Autoimmune Disease Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Autoimmune Disease Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Autoimmune Disease Therapeutics Market Value, By Country, 2018 – 2028
TABLE  MEA Autoimmune Disease Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  MEA Autoimmune Disease Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  MEA Autoimmune Disease Therapeutics Market Value, By Country, 2018 – 2028
TABLE  Amgen Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  F. Hoffmann-La Roche Ag: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bayer Schering Pharma Ag: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Biogen Idec Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bristol-Myers Squibb Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Eli Lilly And Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Abbott Laboratories: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Genentech Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck & Co. Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Johnson & Johnson Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Autoimmune Disease Therapeutics Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Autoimmune Disease Therapeutics Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Autoimmune Disease Therapeutics Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Autoimmune Disease Therapeutics Market, By Geography, 2019 (US$ Mn)
FIG.  Global Autoimmune Disease Therapeutics Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Autoimmune Disease Therapeutics Providers, 2016
FIG.  Global Autoimmune Disease Therapeutics Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Anti-Inflammatory Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Corticosteroids Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Nonsteroidal anti-inflammatory drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Biologics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Autoimmune Disease Therapeutics Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Clinics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Drug Stores Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Independent pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Autoimmune Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Autoimmune Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Autoimmune Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Autoimmune Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Autoimmune Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Autoimmune Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Autoimmune Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Autoimmune Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Autoimmune Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Autoimmune Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Autoimmune Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Autoimmune Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Autoimmune Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Autoimmune Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Autoimmune Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Autoimmune Disease Therapeutics Market Value, 2018 – 2028, (US$ Mn)